(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
...
Trevena (TRVN) said Wednesday that a study on Olinvyk, which is intended for the management of acute pain, showed a statistically significant reduced...
Trevena (TRVN) said Monday that it has secured the first $15 million tranche from its royalty-based financing agreement with an affiliate of R-Bridge...
Trevena (TRVN) said Thursday it has obtained a royalty-based financing of up to $40 million from R-Bridge Healthcare Fund. The biopharmaceutical company...
Trevena (TRVN) said Thursday that partner Jiangsu Nhwa Pharmaceutical has filed a new drug application with China's National Medical Products...
Trevena (TRVN) said Monday it will advance TRV045 into an early stage trial for the potential treatment of diabetic neuropathic pain, a complication of...
...
Trevena (TRVN) said Thursday data from its proof-of-concept study of TRV027 for treating hospitalized COVID-19 patients showed the drug was well-tolerated...
Trevena (TRVN) reported that the Wake Forest Baptist Health Medical Center will join a study that is examining the impact of Olinvyk injection on...